Implementation of paediatric precision oncology into clinical practice: The Individualized Therapies for Children with cancer program ‘iTHER’Karin P.S. Langenberg, Patrick Kemmeren, Michael T. Meister et al.|European Journal of Cancer|2022Cited by 61
The Development of New Agents for Post-Hematopoietic Stem Cell Transplantation Non-Infectious Complications in ChildrenUri Ilan, Francisco Bautista, Caroline A. Lindemans et al.|Journal of Clinical Medicine|2023Cited by 6
Drug Response Profiling Informs Personalized Bridging to Cell Therapy for Patients with Relapsed/Refractory Acute Lymphoblastic LeukemiaFabio D. Steffen, Jean‐Pierre Bourquin, Andrej Lissat et al.|Blood|2023Cited by 1
Corrigendum to “Implementation of paediatric precision oncology into clinical practice: The individualized therapies for children with cancer program ‘iTHER’” [Eur J Cancer 175 (2022) 311–325]Karin P.S. Langenberg, Patrick Kemmeren, Michael T. Meister et al.|European Journal of Cancer|2025Cited by 1